European Archives - Page 1212 of 1555 - European Medical Journal

Leo Pharma’s Gitte Aabo on the power of patient centricity

Gitte Aabo, President and CEO, LEO Pharma A/S, speaks about LEO’s leading position in dermatology and life-changing moments which help foster the patient-centric environment and mindset that is embedded so deeply within the company.

Roundtable: the singular best move for medical affairs

How can medical affairs teams construct a game plan to make sure they are prepared for the changing landscape within big data?

Only the brave marketers will succeed

Amid the digital and data revolution, the rise of social media, and increasing consumer expectations, pharma marketers must up their game to beat competitors.

New Insights into Genetic Risk Factors for Varicose Veins

Varicose veins are more likely to occur the taller a person is, according to a new study from Stanford University, California, USA, which also identified…

Racial Disparity in Genetic Predisposition to Early-Onset Atrial Fibrillation

Black and Latino people are more genetically pre-disposed to early-onset atrial fibrillation (AFib) than white people, according to researchers from the…

EMJ Reproductive Health 4 [ePrint] 2018 (German)

This years European Society of Human Reproduction and Embryology (ESHRE) Congress, was held in Barcelona, Spain. EMJ is proud to bring you a…

Liver Disease Drug May Help with Alzheimer’s Treatment

A readily available drug has been shown to have beneficial therapeutic effects in the treatment of Alzheimer’s disease. The study, which took place at…

Hepatitis C Virus Treatment Just as Effective in the Elderly Population

Elderly patients infected with the hepatitis C virus (HCV) can be treated with direct-acting antivirals (DAA) safely and effectively, according to new…

Hyponatraemia Patients May Benefit from Treatment with Oral Urea

Treatment with oral urea could represent a simple solution to hyponatraemia, suggest the results of a recent study by Dr Helbert Rondon-Berrios and…

Hormone Therapy for Prostate Cancer May Increase the Risk of Liver Disease

Androgen deprivation therapy (ADT) may result in an increased risk of developing nonalcoholic fatty liver disease (NAFLD) and other forms of liver…